Axura

E494107

Axura is a brand-name medication containing memantine, commonly prescribed to treat moderate to severe Alzheimer's disease by helping regulate abnormal activity of the neurotransmitter glutamate in the brain.

All labels observed (1)

Label Occurrences
Axura canonical 1

How this entity was disambiguated

Statements (40)

Predicate Object
instanceOf brand-name medication ⓘ
memantine-containing medicine ⓘ
actsOn central nervous system ⓘ
affects glutamatergic neurotransmission ⓘ
commonAdverseEffect constipation ⓘ
dizziness ⓘ
headache ⓘ
hypertension ⓘ
somnolence ⓘ
contraindication hypersensitivity to memantine ⓘ
drugClass anti-dementia drug ⓘ
elimination primarily renal ⓘ
formulation film-coated tablet ⓘ
oral solution ⓘ
hasActiveIngredient memantine ⓘ
hasDosageForm 10 mg tablet ⓘ
20 mg tablet ⓘ
hasGenericEquivalent memantine ⓘ
indication moderate Alzheimer's disease ⓘ
severe Alzheimer's disease ⓘ
intendedUse long-term treatment ⓘ
mechanismOfAction blocks NMDA receptors ⓘ
reduces pathological effects of excess glutamate ⓘ
regulates abnormal glutamatergic neurotransmission ⓘ
metabolism partially hepatic ⓘ
onsetOfAction gradual ⓘ
pharmacologicalClass NMDA receptor antagonist ⓘ
pregnancyCategory use only if clearly needed ⓘ
regulates glutamate activity ⓘ
regulatoryStatus prescription-only medicine ⓘ
requiresPrescription true ⓘ
routeOfAdministration oral ⓘ
targetPopulation adult patients ⓘ
elderly patients ⓘ
therapeuticArea neurology ⓘ
psychiatry ⓘ
treats Alzheimer's disease ⓘ
usedAs adjunct therapy for Alzheimer's disease ⓘ
monotherapy for Alzheimer's disease ⓘ
usedIn treatment of dementia in Alzheimer's disease ⓘ

How these facts were elicited

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

Memantine → isMarketedUnderBrandName → Axura ⓘ
subject linked to: memantine